UA92638U - Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension - Google Patents
Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertensionInfo
- Publication number
- UA92638U UA92638U UAU201403247U UAU201403247U UA92638U UA 92638 U UA92638 U UA 92638U UA U201403247 U UAU201403247 U UA U201403247U UA U201403247 U UAU201403247 U UA U201403247U UA 92638 U UA92638 U UA 92638U
- Authority
- UA
- Ukraine
- Prior art keywords
- comorbid
- patients
- end points
- unstable angina
- arterial hypertension
- Prior art date
Links
- 206010002388 Angina unstable Diseases 0.000 title abstract 2
- 208000007814 Unstable Angina Diseases 0.000 title abstract 2
- 208000037849 arterial hypertension Diseases 0.000 title abstract 2
- 201000004332 intermediate coronary syndrome Diseases 0.000 title abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 230000002930 anti-sclerotic effect Effects 0.000 abstract 1
- 229960005370 atorvastatin Drugs 0.000 abstract 1
- VHYCDWMUTMEGQY-UHFFFAOYSA-N bisoprolol Chemical compound CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1 VHYCDWMUTMEGQY-UHFFFAOYSA-N 0.000 abstract 1
- 229960002781 bisoprolol Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 abstract 1
- 229960002582 perindopril Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for preventing the emergence of the primary end points in the patients with unstable angina with comorbid arterial hypertension consists in the use of Bisoprolol as beta-adrenoblocker at a daily dose of 5-10 mg, Perindopril as an inhibitor of angiotensin-converting enzyme at a daily dose of 5-10 mg, Atorvastatin as antisclerotic drug at a daily dose of 20 mg, and acetylsalicylic acid at a daily dose of 75 mg for two years.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201403247U UA92638U (en) | 2014-03-31 | 2014-03-31 | Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201403247U UA92638U (en) | 2014-03-31 | 2014-03-31 | Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA92638U true UA92638U (en) | 2014-08-26 |
Family
ID=52682033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201403247U UA92638U (en) | 2014-03-31 | 2014-03-31 | Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA92638U (en) |
-
2014
- 2014-03-31 UA UAU201403247U patent/UA92638U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021003230A (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM. | |
| MX2020009780A (en) | Autotaxin inhibitor compounds. | |
| ZA201700196B (en) | Methods for treating high cardiovascular risk patients with hypercholesterolemia | |
| MX2016002580A (en) | Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases. | |
| EP3513789A3 (en) | Prophylactic and therapeutic agents for fgfr3 diseases | |
| CY1121999T1 (en) | PHARMACEUTICAL FORMS OF DARUNAVIR COMBINATION | |
| BR112017000730B8 (en) | PYRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS, AND DRUGS | |
| MX341976B (en) | Darunavir formulations. | |
| MX2016015261A (en) | Allisartan isoproxil solid dispersion and pharmaceutical composition thereof. | |
| EP3915565A3 (en) | Xanthine oxidase inhibitor formulations | |
| PH12015502706B1 (en) | Oral formulation for the treatment of cardiovascular diseases | |
| MX2015007945A (en) | Uses and methods for the treatment of liver diseases or conditions. | |
| TN2011000214A1 (en) | Combination of hsp90 and herceptin inhibitors | |
| UA92638U (en) | Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension | |
| EA201790772A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING BETA-BLOCKER AND INHIBITOR ANGIOTENZIN-CONVERTING ENZYME | |
| UA92641U (en) | Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertension | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| UA106905U (en) | Pharmaceutical formulation | |
| UA97716U (en) | MEDICINE IN THE FORM OF SYRUP CONTAINING FENSPIRIDE HYDROCHLORIDE | |
| UA90884U (en) | Method for treating pulmonary arterial hypertension in comorbid chronic obstructive pulmonary disease and hypertension | |
| UA83498U (en) | Method for correcting calcium metabolism in patients with arterial hypertension combined with osteoarthrosis | |
| IN2013MU03310A (en) | ||
| UA88462U (en) | Solid dosage form of drug with sedative and hypnotic effects | |
| UA99455U (en) | Method for treating patients with therapy-resistant alcohol dependence | |
| UA93429U (en) | Method for improving efficacy of preventing cardiovascular complications in patients with osteoarthrosis |